Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

Carboplatin 129pembrolizumab 124Cisplatin 114Paclitaxel 103Gemcitabine 84Specimen Handling 81Magnetic Resonance Spectroscopy 81Docetaxel 71Dexamethasone 61Cyclophosphamide 61Pemetrexed 55Bevacizumab 55durvalumab 53Doxorubicin 53Radiotherapy 50Radiation 49Capecitabine 48Oxaliplatin 47Fluorouracil 47Vincristine 43Rituximab 43Leucovorin 42Lenalidomide 40Nivolumab 38Etoposide 38atezolizumab 35Letrozole 35Prednisone 32Bortezomib 32Irinotecan 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Hematopoietic Stem Cell Mobilization × 90 days × Clear all
NCT06724237 2026-05-15

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Recruiting
294 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡